| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $8.45B | +16.4% |
| R&D Expense | $2.63B | +6.6% |
| SG&A Expense | $820.0M | +16.8% |
| Operating Income | $415.0M | +126.8% |
| Interest Expense | $114.0M | +0.0% |
| Pre-tax Income | $638.0M | +79.2% |
| Income Tax | $112.0M | +110.9% |
| Net Income | $526.0M | -61.9% |
| EPS (Basic) | $1.98 |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.54B | -23.3% |
| Short-term Investments | $6.47B | +11.6% |
| Accounts Receivable | $1.95B | +19.0% |
| Current Assets | $10.54B | +6.1% |
| Total Assets | $17.98B | +9.3% |
| Current Liabilities | $5.55B | +9.8% |
| Long-term Debt | $2.98B | +0.1% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.46B | +14.5% |
| Capital Expenditures | $269.0M | +15.9% |
| Investing Cash Flow | -$1.78B | -1.7% |
| Financing Cash Flow | -$1.15B | -329.1% |
| Free Cash Flow | $2.19B | +14.3% |
| -62.5% |
| EPS (Diluted) | $1.95 | -62.6% |
| Total Liabilities |
| $8.94B |
| +6.8% |
| Stockholders' Equity | $9.03B | +11.8% |